Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Journal stats
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
  • Clinical Research and Public Health
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • ASCI Milestone Awards
    • Video Abstracts
    • Conversations with Giants in Medicine
  • Reviews
    • View all reviews ...
    • Emerging therapeutic strategies in breast cancer (Oct 2026)
    • The cGAS-STING pathway: DNA sensing in health and disease (Jun 2026)
    • Neurodegeneration (Mar 2026)
    • Clinical innovation and scientific progress in GLP-1 medicine (Nov 2025)
    • Pancreatic Cancer (Jul 2025)
    • Complement Biology and Therapeutics (May 2025)
    • Evolving insights into MASLD and MASH pathogenesis and treatment (Apr 2025)
    • View all review series ...
  • Viewpoint
  • Collections
    • In-Press Preview
    • Clinical Research and Public Health
    • Research Letters
    • Letters to the Editor
    • Editorials
    • Commentaries
    • Editor's notes
    • Reviews
    • Viewpoints
    • 100th anniversary
    • Top read articles
  • Search Articles

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • ASCI Milestone Awards
  • Video Abstracts
  • Conversations with Giants in Medicine
  • In-Press Preview
  • Clinical Research and Public Health
  • Research Letters
  • Letters to the Editor
  • Editorials
  • Commentaries
  • Editor's notes
  • Reviews
  • Viewpoints
  • 100th anniversary
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Journal stats
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
LSD1-mediated demethylation of the DNA damage response factor ATM promotes senescence and organ aging
Yingying Zhang, Chen Yu, Xiaoqin Zhang, Linda Xiaoyan Li, Alice Shasha Cheng, Xiaogang Li
Yingying Zhang, Chen Yu, Xiaoqin Zhang, Linda Xiaoyan Li, Alice Shasha Cheng, Xiaogang Li
View: Text | PDF
Research Article Aging Cell biology

LSD1-mediated demethylation of the DNA damage response factor ATM promotes senescence and organ aging

  • Text
  • PDF
Abstract

Aging occurs heterogeneously across organs, leading to progressive tissue dysfunction. Cellular senescence is a stress response triggered by age-associated insults, yet the mechanisms regulating senescence and organ aging remain incompletely understood. Here, we defined a role for lysine-specific demethylase 1 (LSD1) in DNA damage–mediated senescence and organ aging. LSD1 was upregulated in aged organs and senescent cells. In response to natural aging or ionizing radiation–induced DNA damage, LSD1 interacted with and demethylated ATM at lysine 3,016, as confirmed using a newly generated ATM-K3016me antibody. This modification sustained ATM phosphorylation, amplified DNA damage signaling, and delayed checkpoint recovery, promoting senescence and organ aging. Inhibition of LSD1 accelerated ATM dephosphorylation via WIP1, enhanced DNA repair, reduced senescence and DNA damage, and prevented irradiation-induced hair graying. Elimination of senescent cells with senolytics reduced LSD1 protein in aged organs, indicating a feedback loop between LSD1 and senescence. Mechanistically, LSD1 underwent autophagosome-lysosome degradation through interaction with LC3 and Beclin1, and autophagy impairment during DNA damage contributed to LSD1 accumulation in senescent cells. This study revealed LSD1 as a key regulator of DNA damage–induced senescence and organ aging and suggested that targeting LSD1 may attenuate senescence, delay organ aging, and prevent hair graying.

Authors

Yingying Zhang, Chen Yu, Xiaoqin Zhang, Linda Xiaoyan Li, Alice Shasha Cheng, Xiaogang Li

×

Figure 1

The expression of LSD1 is increased in aged organs and senescent cells.

Options: View larger image (or click on image) Download as PowerPoint
The expression of LSD1 is increased in aged organs and senescent cells.
...
(A–F) Western blot analysis of the expression of LSD1, p16, and p21 in aged organs, including kidneys (A), hearts (B), livers (C), spleens (D), lungs (E), and intestines (F), collected from 20–22-months-old mice (Aged) compared with expression in young organs collected from 2-month-old mice (Young). n = 6. (G–I) qRT-PCR analysis of Lsd1 (G), p16 (H), and p21 (I) mRNA in mouse organs, including kidney, heart, liver, spleen, lung, and intestine, collected from young and aged mice (n = 6, per group; ns, not significant; **P < 0.01; unpaired, 2-tailed Student’s t test). (J) Western blot analysis of the expression of LSD1, Cyclin D, p16, and p21 from whole-cell lysates of mouse IMCD cells treated with D-galactose (D-Gal) and etoposide (ETO) for 48 hours with different doses. Represent data from 3 independent experiments are shown. (K) Western blot analysis of the expression of LSD1, Cyclin D, p16, and p21 in mouse IMCD cells cultured after 100% confluency for indicated days. Represent data from 3 independent experiments are shown. (L) qRT-PCR analysis of Lsd1 (L) mRNA in mouse IMCD cells treated with D-Gal (left panel) and ETO (right panel). All experiments were independently repeated at least 3 times; ns, not significant; unpaired, 2-tailed Student’s t-test (M and N) qRT-PCR analysis of p16 (M) and p21 (N) mRNAs in mouse IMCD cells treated with D-Gal or ETO. All experiments were independently repeated at least 3 times; **P < 0.01; unpaired, 2-tailed Student’s t-test.

Copyright © 2026 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts